MedStack
A healthcare compliance automation platform that gives digital health developers infrastructure-as-code tooling and pre-built policies to meet HIPAA and SOC 2 requirements out of the box.
Visit Website ↗ + Add to CompareOverview
MedStack automates a problem that otherwise consumes enormous amounts of engineering and legal time at digital health startups: proving HIPAA and SOC 2 compliance for cloud infrastructure. Its flagship product, MedStack Control, uses infrastructure-as-code to provision AWS or Azure resources that are pre-configured to meet HIPAA and SOC 2 technical controls, paired with pre-written, industry-validated compliance policies and security-questionnaire responses that developers would otherwise have to draft themselves or pay consultants to produce.
The company reports that running applications on MedStack Control automatically covers a substantial share of what’s required for HIPAA (up to roughly 75%) and SOC 2 (up to roughly 60%) compliance, backed by a Business Associate Agreement (BAA) provided to every customer — a concrete contractual commitment, not just a marketing claim. This targets a real and specific pain point: digital health companies need to demonstrate compliance to enterprise health system customers and payers before they can close deals, and building that infrastructure from scratch is slow and error-prone for small teams.
Founded in 2015 and based in Toronto, MedStack completed an asset sale to Launchit Solutions, a Hamilton, Ontario-based health technology studio, in November 2024. MedStack’s products and brand (MedStack Control and Exos by MedStack) continue to operate under Launchit, with MedStack’s co-founder and CEO joining as Launchit’s Chief Product Officer — a continuation rather than a shutdown, though the change in ownership structure is worth noting for procurement due diligence.
Innovation Matrix Assessment
MedStack maintained two active products (Control and Exos) over roughly a decade and continues shipping under new ownership, but the November 2024 acquisition introduces roadmap uncertainty since future investment priorities are now set by Launchit Solutions rather than an independent MedStack team.
MedStack raised a modest ~$5.5M across its independent life and was acquired rather than scaling to a large independent operation; it now functions as a product line inside a larger health-tech studio (Launchit) rather than a standalone company.
The company's independent momentum culminated in an acquisition rather than continued independent growth; the November 2024 asset sale to Launchit Solutions is the most significant and most recent event in its trajectory.
Automating a meaningful share of HIPAA/SOC 2 technical controls via infrastructure-as-code, bundled with a contractual BAA, is a genuinely useful compressed path to compliance for small health-tech teams, though compliance-automation-as-a-service is not itself a new category.
The Business Associate Agreement MedStack provides to every customer is a binding contractual commitment tied to specific compliance coverage claims, which is stronger accountability than an unverified marketing statistic, though the specific 75%/60% coverage figures are MedStack's own estimates rather than an independent audit.
Digital health companies continue to face significant time and cost pressure to prove HIPAA/SOC 2 compliance before enterprise health system and payer customers will sign contracts, keeping this a persistently relevant problem for the sector.
Why CISOs Should Care
For security and compliance leaders at digital health startups, MedStack Control compresses the time and specialist expertise needed to stand up HIPAA/SOC 2-ready cloud infrastructure, backed by a contractual BAA rather than a self-certification checklist alone.
What Makes It Different
It combines infrastructure-as-code provisioning with pre-written, industry-validated compliance policy documentation and a contractual BAA, addressing both the technical and paperwork sides of healthcare compliance in one product.
The Matrix Verdict
53/100 — INCREMENTAL INNOVATOR
A useful, purpose-built compliance automation tool for a real and specific healthcare pain point, now operating as an acquired product line inside Launchit Solutions rather than as an independent growth-stage company.
Editorial Note: Claims vs. Verified Findings
The Launchit Solutions acquisition and MedStack's continued operation as a branded product line are independently confirmed by law-firm deal announcements (Fasken, Canadian Lawyer); the specific HIPAA/SOC 2 percentage-coverage figures are MedStack's own estimates and have not been independently audited.
Sources
Alternatives to MedStack
Vanta
Continuous automated compliance monitoring platform that replaces manual audit evidence-gathering with live, integration-based control checks.
AuditBoard (rebranded Optro)
Connected-risk platform for audit, SOX, risk, and compliance, recently rebranded from AuditBoard to Optro under an AI-agent-driven repositioning.
Arcova
Cybersecurity advisory and managed services firm, rebranded from MorganFranklin Cyber, offering GRC, IAM, OT security, and a cloud-based…
Credo AI
AI governance platform that discovers, assesses, and continuously monitors enterprise AI systems and agents against regulations like the…
Level 6 Cyber
CISO ReviewedContinuous decision-intelligence platform (LISN) that replaces point-in-time security audits with a live digital twin of a CISO's program.
Drata
Continuous compliance automation platform, Vanta's closest direct competitor, covering SOC 2, ISO 27001/42001, HIPAA, PCI DSS, DORA, and…